Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Descourt

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Revue Des Maladies Respiratoires|May 21, 2018
[A very unusual pleural presentation]F Vergne, R Le Mao, L Simonin, et al.
Revue Des Maladies Respiratoires|December 22, 2019
[Evolution of the costs and management of lung cancer between 2004 and 2014]F Gadby, R Descourt, G Robinet, et al.
Revue Des Maladies Respiratoires|June 8, 2011
[Effect of tinzaparin on survival in non-small-cell lung cancer after surgery. TILT: tinzaparin in lung tumours]G Meyer, B Besse, S Friard, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2014
Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 studyJ B Auliac, C Chouaid, L Greillier, et al.
ESMO Open|July 24, 2025
Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysisK Amrane, B Cabarrou, G Justeau, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Revue Des Maladies Respiratoires|May 21, 2018
[A very unusual pleural presentation]F Vergne, R Le Mao, L Simonin, et al.
Revue Des Maladies Respiratoires|December 22, 2019
[Evolution of the costs and management of lung cancer between 2004 and 2014]F Gadby, R Descourt, G Robinet, et al.
Revue Des Maladies Respiratoires|June 8, 2011
[Effect of tinzaparin on survival in non-small-cell lung cancer after surgery. TILT: tinzaparin in lung tumours]G Meyer, B Besse, S Friard, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2014
Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 studyJ B Auliac, C Chouaid, L Greillier, et al.
ESMO Open|July 24, 2025
Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysisK Amrane, B Cabarrou, G Justeau, et al.
Pageof 2